Page results
-
A UCLH patient with a rare hormonal condition is the first in the world to receive a new investigational drug in a first-in-human trial.
-
Information about the Integrated General Medicine Service at the RLHIM patient information leaflet.
-
Find & Treat's new prototype Eco-Tricycle will visit parks, hostels, soup kitchens, be able to arrive under bridges or other street outreach locations to screen homeless patients for infectious diseases and more.
-
UCLH has been selected as the lead site in Great Britain for Neuralink’s GB-PRIME study, a clinical investigation for Neuralink’s brain-computer interface (BCI).
-
This information is for patients who have attended the emergency department with an undisplaced or minimally displaced fracture (broken bone) at the base of your 5th metatarsal.
-
Tasnim tells us about her experience training with the Pharmacy team at UCLH and how their support has encouraged her to pursue this career.
-
Today we are launching the new UCLH strategy for 2023-2027. Developed with staff, patients and key partners, the strategy sets the future direction of UCLH over the next five years.
-
Easy read information for patients living with a catheter.
-
This diary is intended for patients undergoing thoracic surgery as a way of involving you in your recovery before your surgery as well as after.
-
Information for patients undergoing VATS for drainage of air or fluid, pleural biopsies and talc pleurodesis.
File results
-
FOI/2023/0124 - Clinical decision support in e-prescribing, Observations vital signs, Oncology e-prescribing and Diagnostic imaging systems
-
FOI/2023/0126 - Repayment fees for internationally recruited nurses
-
FOI/2023/0127 - Organisational structure for finance managers
-
FOI/2023/0131 - Training for first aid, life support, CPR and resuscitation/ defibrillator
-
FOI/2023/0132 - Renal cell carcinoma and melanoma treatment
-
FOI/2023/0138 - Subject Access Requests (SARs) and Freedom of Information Requests
-
FOI/2023/0145 - Waiting times for consultant-led treatment, inpatient and outpatients
-
FOI/2023/0155 - Patient transport policy
-
FOI/2023/0152 - Wheelchair associated services
-
FOI/2023/0122 - Usage of Pembrolizumab for the treatment of melanoma